Epitomee Medical

Drug-free Capsules for Diabetes Prevention and Weight Loss

Health Tech & Life Sciences
Public on TASE on Dec, 2021

Company Overview

Snapshot

Founded in August 2005 by Dr. Shimon Eckhouse, Epitomee Medical operates with 11–50 employees. The company has raised a total of $77 million across four funding rounds from six investors. Epitomee Medical went public on TASE in December 2021, raising $60 million.

Business overview

Epitomee Medical is a public company focused on developing and commercializing ingestible therapeutic devices for chronic diseases. Its core technology utilizes self-expanding hydro-gel scaffolds, folded into standard pharmaceutical capsules, made from biocompatible excipients, food additives, and food contact materials. These hydro-gel scaffolds can be engineered to trigger at specific pH levels, enabling targeted deployment for optimal therapeutic effects. The company operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics, serving both healthcare and consumer markets globally.

Strategic signal

In September 2024, Epitomee Medical announced FDA clearance for its capsule weight management device. This regulatory approval is a significant validation of the company's technology and opens a critical market for its drug-free solution, signaling strong commercial potential and a clear path to market expansion for investors.

Company Intelligence Q&A

What was a key recent regulatory milestone for Epitomee Medical?
In September 2024, Epitomee Medical announced that the United States Food and Drug Administration (FDA) officially cleared its Epitomee® capsule weight management device.
When did Epitomee Medical go public?
Epitomee Medical went public on TASE in December 2021, raising $60 million.
What was the outcome of the RESET Study for Epitomee's drug-free capsule?
In November 2024, results from Epitomee's RESET Study, demonstrating that its drug-free capsule helps patients shed pounds, were presented at ObesityWeek® 2024.
What was a significant development regarding Epitomee's weight loss capsule in early 2024?
In January 2024, Epitomee announced the successful completion of a pivotal clinical trial for its innovative weight loss capsule.
What was the outcome of Epitomee Medical's clinical trial results in November 2023?
In November 2023, clinical trial results for Epitomee Medical's weight loss pill led to a surge in its stock.

External links